NCT06324825View on ClinicalTrials.gov

Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial

NARecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

October 24, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Atrophic Gastritis With Low-grade Intraepithelial Neoplasia
Interventions
DRUG

Fuzhegn Nizeng Decoction

Subjects taking prepared Fuzhegn Nizeng granules twice daily for 6 month.

DRUG

Moluodan granules

Subjects taking prepared Moluodan granules 9g twice daily for 6 month.

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER